ESG investing is no new concept, but it has certainly exploded in importance over the past few years. The market grew to $715bn last year according to the Global Impact Investing Network, while market participants have also expanded in terms of numbers, knowledge and ideas.
Alternative protein investor Lever VC founder and managing partner Nick Cooney talked AltAssets through the positives and negatives of the growing market, and shared his investment strategies for the next few years. The post How
Rising private equity dealmaking is helping global M&A activity towards what could become its most active year on record, new research shows. The post Rising PE activity at heart of global M&A push for record
Private equity funds soared to a record quarterly return at the start of this year amid a strong recovery of the global economy from the coronavirus pandemic, new data shows. The post Private equity, venture
Widespread destruction from ever-more dangerous climate change events this year has seen swaths of North America, Africa, Siberia and southern Europe consumed by wildfires, mass flooding in Germany and temperatures in Vancouver reaching 50°C. Impact investment funds have been
M&A dealmaking activity has surged in the first half of the year as the recovery from the coronavirus crisis continues, new research shows. The post M&A deals soar following Covid-crisis dip, North America leads way
Software-focused private equity house Alpine Investors closed its eighth investment fund on its $2.25bn hard cap in September, less than four months after launch. Adding to the impressive size and speed was the fact that
European private equity dealmaking has hit a new annual record with three whole months of the year to go, with a surge in deal volume behind the outstanding figures, new research shows. The post Record
Institutional investors remain constructive on private capital markets amid a backdrop of rising inflation, potentially higher interest rates and increased scrutiny on ESG issues, new research from Eaton Partners shows. The post LPs eye uptick
Traditional wisdom might tell you there are opportunities in every risk – but in times of uncertainty, it is just sometimes not so easily compensable. The Covid-19 pandemic has been one of the most uncertain times globally in recent human
Private equity firms are better placed than corporate to take advantage of Covid-19 buying opportunities in Europe, new research suggests. The post PE firms better placed than corporates for European Covid-19 buying opportunities – report
Secondaries private equity deal value is poised to reach more than $100bn by the end of the year amid an ongoing rise in GP-led transactions, new research from Raymond James | Cebile Capital shows. The
More than three-quarters of private equity fund managers expect the volume of cross-border deal flow to make a full return to pre-pandemic levels by the end of next year, new research shows. The post Cross-border
European venture capital valuations saw an "astonishing rise in the first half of the year to reach record highs, new research from PitchBook shows. The post ‘Astonishing’ rise in European VC valuations hasn’t topped out
Far from struggling amid the chaotic Covid-19 environment, Shore Capital managed to pass $2bn in capital under management thanks to a triple fund close this summer - and sealed the most deals in 2020 across
Private equity fundraising continued to accelerate in Q2 to set the stage for what will likely be a record year, new research from PitchBook shows. The post Private equity fundraising accelerates away from Covid woes,
Fintech investor Nyca Partners is back in the fundraising market with the successor to its $210m third fund closed two years ago. The post Fintech investor Nyca Partners back fundraising with follow-up to $210m Fund
European private equity fundraising is on track for a record year after firms hauled in close to €60bn of capital in the first half of the year, new data from PitchBook shows. The post European
Red Door Capital managing partner Richard Wolpow has had a tumultuous couple of years, even ignoring the global pandemic. Having spent 25 years in the financial world jetting from country to country, a nasty accident
The already intensely heated pharmaceutical and medical investment market has grown even more competitive over the past year thanks to rising interest amid the Covid-19 pandemic. Consolidation within the market has also seen the bar
